ATLASLantern Pharma (LTRN) earnings date: Nov 11, 2026
Lantern Pharma (LTRN) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, before the open. Analysts expect EPS of -$0.38.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LTRN
| Last price | $0.66 (-9.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.4% |
| Earnings beat history | Beat the EPS estimate in 6 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Lantern Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Lantern Pharma reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Lantern Pharma. You can switch it off at any time.
Alert me before LTRN reportsFree to start. Creating an account takes under a minute.
LTRN earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.38 |
| Last report | Oct 23, 2026 · Beat |
| Beat rate (last 6 reports) | 6 of 6 (100%) |
| Average EPS surprise | +16.6% |
| Average move around a report | ±5.5% (last 6) |
| Sector | Healthcare · Biotechnology |
Lantern Pharma earnings history: last 6 reports
Lantern Pharma last reported on Oct 23, 2026: EPS of $2.00 against an estimate of $1.95 (+2.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 23, 2026 | $1.95 | $2.00 | +2.6% | Beat | -2.6% |
| Aug 14, 2026 | -$0.38 | -$0.28 | +26.3% | Beat | -1.1% |
| Jun 15, 2026 | $0.13 | $0.15 | +15.4% | Beat | +0.8% |
| May 15, 2026 | -$0.36 | -$0.30 | +16.7% | Beat | -4.2% |
| Mar 30, 2026 | -$0.46 | -$0.36 | +21.7% | Beat | +22.3% |
| Nov 12, 2025 | -$0.47 | -$0.39 | +17.0% | Beat | -2.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LTRN
See the fair value, the probability range and the earnings history of Lantern Pharma on its ATLAS page.
Lantern Pharma (LTRN) stock analysisPlans from €3.99 a month.
Lantern Pharma earnings: frequently asked questions
When does Lantern Pharma (LTRN) report earnings?
Lantern Pharma is scheduled to report on Wednesday, November 11, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for LTRN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.38 per share (USD). Estimates can change before the report.
How often does LTRN beat earnings estimates?
Of its last 6 reports with a recorded result, Lantern Pharma beat the EPS estimate 6 times; the average surprise was +16.6%. Past results do not predict the next one.
How much does LTRN move around earnings?
Over its last 6 reports the stock moved an average of 5.5% (absolute, from the close before the report day to the close after it), and finished higher 2 of 6 times.
Did Lantern Pharma beat earnings estimates last quarter?
Lantern Pharma last reported on Oct 23, 2026: EPS of $2.00 against an estimate of $1.95 (+2.6% surprise), a beat.
How much does LTRN usually move in a day?
On a normal trading day the ATLAS model puts LTRN’s one-day range at about ±6.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer